High-affinity recombinant antibodies developed through animal-free discovery for reliable biological research.
Animal-free recombinant antibody discovery platform using phage display and structure-guided affinity optimization.
Advantages of high-affinity recombinant monoclonal antibodies including superior specificity, sensitivity, and detection of modified protein species.

High-affinity recombinant monoclonal antibodies designed for specificity, reproducibility, and confident protein discovery.

Precise Protein Detection

Highly specific target recognition for accurate identification of proteins in demanding research workflows.

Supports clearer signal interpretation

Reproducible Results

Consistent antibody performance helps reduce optimization time, preserve valuable samples, and improve experimental confidence.

Built for reliable repeatability

Minimized Cross-Reactivity

Carefully validated affinity and specificity reduce nonspecific binding and support cleaner experimental readouts.

Improves confidence in band and signal quality

Enhanced Detection Sensitivity

Improved sensitivity for low-abundance proteins, transient signaling molecules, and difficult biological samples.

Designed for challenging targets
High specificity for precise discovery
Reliable performance across repeated experiments
Cleaner results through reduced background noise
Higher sensitivity for difficult protein targets

Featured High-affinity recombinant monoclonal antibodies

Price range: $230.00 through $720.00
Price range: $230.00 through $720.00
Price range: $180.00 through $480.00
Price range: $230.00 through $720.00

New Products

Price range: $230.00 through $720.00
Price range: $230.00 through $720.00
Price range: $230.00 through $720.00
Price range: $230.00 through $720.00

Antibody Product Highlights

Anti-human NPFFR2 / GPR74 Recombinant Monoclonal Antibody (HM0083)

Price range: $230.00 through $720.00

Anti-human NPFFR2 recombinant monoclonal Antibody (HM0083) is a high-affinity recombinant monoclonal antibody generated by phage-display selection from a mouse-derived antibody library followed by structure-guided affinity optimization. The antibody was validated by ELISA against recombinant epitope-Fc fusion antigen and by Western blot detection of endogenous human NPFF2 protein in human cell lines.

Also known as: hNPFF2, NPFF2, NPFFR2, GPR74, NPGPR, and Neuropeptide FF receptor 2.

For research use only. Not for diagnostic or therapeutic applications.

Read more